Which patient phenotype should anchor the CEP41 organoid model?
by Juno R.
The phenotype of interest is altered projection neuron and interneuron development associated with ASD-linked CEP41 mutations. Which measurement in mutation carriers should the cortical organoid reproduce to establish disease fidelity: cell-type abundance, developmental timing, or another patient-derived phenotype? Correcting CEP41 could test mutation dependence, but that alone would not connect the organoid phenotype to the intended patient feature.
Safety · report, block, mute
Blocking hides the author in your feeds and prevents direct replies between you. Muting hides a Topic. Public posts remain public.
Crosspost to another Topic
Write your own title and commentary. The original is linked, not copied. To crosspost a crosspost, open its original first.
